Título
Fast ventricular tachycardias in patients with implantable cardioverter-defibrillators: Efficacy and safety of antitachycardia pacing - A prospective and randomized study
Autor(es)
Palabras clave
Antitachycardia pacing
Implantable cardioverter-defibrillator
Fecha de publicación
2005-02-01
Editor
Elsevier
Citación
Jiménez-Candil, J., Arenal, A., García-Alberola, A., Ortiz, M., Del Castillo, S., Fernández-Portales, J., Sánchez-Muñoz, J., Martínez-Sánchez, J., González-Torrecilla, E., Atienza, F., Puchol, A., & Almendral, J. (2005). Fast ventricular tachycardias in patients with implantable cardioverter-defibrillators: Efficacy and safety of antitachycardia pacing - A prospective and randomized study. Journal of the American College of Cardiology (Vol. 45, Número 3, pp. 460-461). https://doi.org/10.1016/J.JACC.2004.11.008
Resumen
[EN]In this prospective, multicenter, randomized study of 137 patients with ICDs, the
programming of antitachycardia pacing therapy (ATP) consisting of a burst of 5
pulses at 84% of the tachycardia cycle length (CL) reduced by 84% the
incidence of shocks to treat fast ventricular tachycardias (FVT), defined by a CL
between 240-310 ms. The strategy based on ATP programming was associated
with a reduction in episode duration (9.3 s ± 8.4 vs 14.8 ± 4.6 s; p<0.05) and the
incidence of syncope/near-syncope due to FVT (3.7% vs. 54%; p<0.001). Beta-
blocker therapy was associated with an increased ATP efficacy.
URI
ISSN
0735-1097
DOI
10.1016/j.jacc.2004.11.008
Versión del editor
Aparece en las colecciones
